NOCIL Q2 FY27 Share Price & Earnings Call Analysis

₹145.35-0.92% today
Market cap
₹2,424 Cr
P/E
34.85
ROE
2.60%
PEG
-1.07
Price to sales
1.75
Debt to equity
0.00
52W high / low
₹206 / ₹128
Sales growth (5Y)
7.10%
EBITDA margin
8.43%
Net profit margin
3.53%
Promoter holding
33.76%
Sales (last year)
₹1,370 Cr

NOCIL Ltd., incorporated in 1961, manufactures rubber chemicals which are used by the tyre industry and other rubber processing industries.[1] It is a part of Arvind Mafatlal Group and is the Largest Rubber Chemicals Manufacturer in India.

Guidance scorecard · Q2 FY27 call

What NOCIL Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#55of 71 in
Chemicals & Petrochemicals

RevenueQ1 FY27 call

10–20%
  • NOCIL expects revenue for FY27 to be in the range of Rs 1,400 to Rs 1,600 crores, based on the current pricing environment.
  • The company targets around 10% volume growth for the full year FY27.
  • EBITDA margin is expected to hover around 10% for FY27, supported by volume growth and operating leverage.
  • Export volumes aim to grow from around 33% currently to approximately 40-45% by FY28-29, indicating an increased focus on international markets.
  • Specialty segment, constituting 15% of the current topline, is expected to increase by an additional 5-10%, reaching around 20-25% of total revenue in 1-2 years.

2 more points from NOCIL Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what NOCIL Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • NOCIL is progressing well with a new Rs 130 crore investment in Dahej.
  • The Rs 130 crore investment is on track despite challenges due to the Middle East geopolitical situation.
  • Trial production at the new TDQ plant in Dahej has started, with sample approvals underway.
  • Commercial volumes from the TDQ plant are expected to start trickling in by Q4 FY27 and ramp up more significantly in Q1 FY28.
  • The investment in the TDQ plant aims to reinforce NOCIL's competitive market position.

2 more points from NOCIL Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what NOCIL Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • The company faced temporary supply-side constraints and logistical challenges in Q1 FY27, causing a moderate 3% sequential volume decline and postponement of certain order commitments.
  • Customer demand remains healthy despite operational issues, and the company is confident of recovering deferred volumes in upcoming quarters.
  • Trial production at the new TDQ plant is underway, with sample approvals progressing and commercial supplies expected to ramp up starting Q4 FY27 and more significantly in Q1 FY28.
  • NOCIL is working closely with suppliers and logistics partners to normalize supplies and fulfill pending orders.
Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Financials of NOCIL Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

NOCIL Ltd

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +33.84%33.84%33.84%33.78%33.78%33.76%33.76%33.76%33.76%33.76%33.76%33.76%
FIIs +6.98%7.77%7.77%7.92%7.82%8.15%6.65%5.16%4.47%4.55%4.78%5.29%
DIIs +2.83%3.51%4.44%6.13%5.93%5.33%5.20%6.57%6.50%7.92%7.48%6.96%
Public +56.36%54.87%53.95%52.18%52.47%52.76%54.39%54.52%55.27%53.79%53.99%54.00%
No. of Shareholders1,76,3471,71,4961,67,1571,66,6271,63,8991,61,8251,65,6481,64,8171,62,1671,65,8351,61,3421,56,030

Financials of NOCIL Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +351341356372363318340336321316330403427
Expenses +306292312331325294305306298289309358391
Operating Profit45494541382434312227214536
OPM %13%14%13%11%10%8%10%9%7%8%6%11%8%
Other Income +5625989671011467
Interest0000100000000
Depreciation13131313131413141414141414
Profit before tax37415637321926231913213728
Tax %26%26%25%26%-30%32%20%25%35%31%19%25%15%
Net Profit +2730422742132117129172824
EPS in Rs1.631.802.491.622.520.771.241.030.730.551.021.661.44

Financials of NOCIL Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +7197157429641,0438469251,5711,6171,4451,3931,3031,476
Expenses +6055755826957506687931,2841,3641,2501,2551,2021,347
Operating Profit114140160269293178132288253195137101129
OPM %16%20%22%28%28%21%14%18%16%14%10%8%9%
Other Income +33911109142639323127
Interest17921111112211
Depreciation14152024243437485653545555
Profit before tax8611914725527815210724120218011476100
Tax %34%34%34%33%33%14%17%27%26%26%10%27%
Net Profit +577897170185131881761491331035678
EPS in Rs3.554.875.9410.3311.177.895.3210.578.957.986.163.334.67
Dividend Payout %28%25%30%24%22%32%38%28%34%38%32%45%

Financials of NOCIL Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital161161164164165166166167167167167167167
Reserves2543097508829981,0201,1191,2791,3851,5321,5951,6061,639
Borrowings +14726155076610131087
Other Liabilities +193186233279279250324380295304284329376
Total Liabilities7556821,1611,3311,4421,4421,6151,8301,8572,0152,0572,1112,189
Fixed Assets +311307543528657797918909888870855831814
CWIP3644213115614891660221272
Investments2222176281130546853218399366415297
Other Assets +418347438480524434614859742730776645807
Total Assets7556821,1611,3311,4421,4421,6151,8301,8572,0152,0572,1112,189

Financials of NOCIL Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +3017014210216417994-3028220126252
Cash from Investing Activity +-5-12-11-141-101-106-5831-217-77-37-212
Cash from Financing Activity +-33-151-31-43-50-1010-34-54-55-50-38
Net Cash Flow-88101-8213-2835-331168-622
Free Cash Flow2115612955-73-067-66253184-9584
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit43%144%117%68%86%129%71%10%131%124%44%274%

Financials of NOCIL Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days85778292818812210478868181
Inventory Days17613511612913312812014111710012975
Days Payable7974829677841239152535472
Cash Conversion Cycle18213811612513813211915414313315684
Working Capital Days718686949910411412810811013091
ROCE %19%24%21%26%25%13%9%18%13%10%6%4%

Guidance history

How NOCIL Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%FlatPlanned——
Q4 FY26 call →10–20%—PlannedNone planned—
Q3 FY26 call →10–20%FlatPlanned——
Q2 FY26 call →0–10%FlatPlanned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

15out of 100

Momentum score · price trend

15 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−21.9%34%
Last 6 months−19.0%20%
Last 3 months−9.0%43%

The price is 54.3% below its all-time high of ₹318.3 (2 Aug 2024). Stocks more than 20% below their peak have their score halved, so 30 became 15.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For NOCIL Ltd: 0.4 × 34 + 0.4 × 20 + 0.2 × 43 = 30, halved to 15 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • Alufluoride Ltd (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks